Shares in CureVac have plummeted after a German court ruled that a patent it holds on mRNA-based COVID-19 vaccines was invalid. The validity of the patent is at the heart of patent litigation ...

The European Patent Office has said it has invalidated a patent held by Moderna on mRNA-based COVID-19 vaccines, the latest development in an increasingly acrimonious dispute between the company ...

Dublin, March 11, 2025 (GLOBE NEWSWIRE) -- The "mRNA Cancer Therapeutics Patent Landscape Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering. The mRNA cancer ...

In particular, there is an area near the 5' end of the molecule that is known as the untranslated region (UTR) or leader sequence. This portion of mRNA is located between the first nucleotide that ...

A typical bacterial mRNA transcript controlled by a riboregulatory element such as a riboswitch is composed of three sections: the 5' untranslated region (5' UTR), the protein-coding region ...

Pfizer and BioNTech, which collaborated on the mRNA vaccine, argued that Moderna—in a press statement from October ...

March 5 - Pfizer (PFE.N), opens new tab and BioNTech (22UAy.DE), opens new tab won a round in their legal battle with Moderna (MRNA.O), opens new tab over COVID-19 vaccine patents on Wednesday ...

Dublin, March 11, 2025 (GLOBE NEWSWIRE) -- The "mRNA Cancer Therapeutics Patent Landscape Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering. The mRNA cancer ...